Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
1.850
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
1.870
+0.020 (1.08%)
After-hours: Dec 20, 2024, 5:41 PM EST
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $379.15 million as of December 20, 2024. Its market cap has increased by 19.29% in one year.
Market Cap
379.15M
Enterprise Value
284.48M
1-Year Change
19.29%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $379.15M, a decrease of -45.09%. That is a compound annual growth rate of -13.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 379.15M | 14.57% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quanterix | 402.98M |
| Akebia Therapeutics | 399.27M |
| Nano-X Imaging | 395.61M |
| Allogene Therapeutics | 392.09M |
| Enhabit | 384.67M |
| REGENXBIO | 377.53M |
| ZimVie | 375.34M |
| Y-mAbs Therapeutics | 370.85M |